Description

Semax represents a synthetic heptapeptide developed as an analogue of adrenocorticotropic hormone fragment 4-10, incorporating specific modifications designed to enhance neuroprotective activity and central nervous system penetration. The compound demonstrates neuroprotective and cognitive-enhancing properties in research models, with mechanisms involving brain-derived neurotrophic factor (BDNF) regulation and neuroplasticity enhancement. The peptide incorporates structural modifications that improve its stability and bioavailability in neurological tissue, making it suitable for investigating neuroprotective mechanisms and cognitive enhancement pathways. Semax functions through multiple mechanisms that may include modulation of neurotrophic factor expression, enhancement of synaptic plasticity, and protection against neurological stress and damage. Research applications include investigation of neuroprotection mechanisms, cognitive enhancement pathways, and the molecular basis of neurological recovery and adaptation. For research use only.